References
- Muto M, Mori M, Sato Y, Uzawa A, Masuda S, Uchida T, et al. Current symptomatology in multiple sclerosis and neuromyelitis optica. Eur J Neurol 2015;22(2):299–304. doi: https://doi.org/10.1111/ene.12566
- Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 2015;85(2):177–89. doi: https://doi.org/10.1212/WNL.0000000000001729
- Kira J. Multiple sclerosis in the Japanese population. Lancet Neurol 2003;2(2):117–27. doi: https://doi.org/10.1016/S1474-4422(03)00308-9
- Ishizu T, Osoegawa M, Mei FY, Kikuchi H, Tanaka M, Takakura Y, et al. Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis. Brain 2005;128(5):188–1002. doi: https://doi.org/10.1093/brain/awh453
- Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 2018;17(2):162–73. doi: https://doi.org/10.1016/S1474-4422(17)30470-2
- Boringa JB, Lazeron RB, Reuling IE, Adèr HJ, Pfennings L, Lindeboom J, et al. The brief repeatable battery of neuropsychological tests: normative values allow application in multiple sclerosis clinical practice. Multiple Scler J 2001;7(4):263–7. doi: https://doi.org/10.1177/135245850100700409
- Kira J. Autoimmunity in neuromyelitis optica and opticospinal multiple sclerosis: astrocytopathy as a common denominator in demyelinating disorders. J Neurol Sci 2011;311(2):69–77. doi: https://doi.org/10.1016/j.jns.2011.08.043
- Abdullah S, Wong WF, Tan CT. The prevalence of anti-aquaporin 4 antibody in patients with idiopathic inflammatory demyelinating diseases presented to a tertiary hospital in Malaysia: presentation and prognosis. Multiple Scler Int 2017;2017:1359761.
- Ramanathan S, Sato S, Matsushita T, Masaki K, Yamasaki R, Dale RC, et al. Antibodies to myelin oligodendrocyte glycoprotein are uncommon in Japanese opticospinal multiple sclerosis. Multiple Scler J 2016;22(1):127–8. doi: https://doi.org/10.1177/1352458515586089
- Lévesque SA, Paré A, Mailhot B, Bellver-Landete V, Kébir H, Lécuyer MA, et al. Myeloid cell transmigration across the CNS vasculature triggers IL-1β-driven neuroinflammation during autoimmune encephalomyelitis in mice. J Exp Med 2016;213(6):929–49. doi: https://doi.org/10.1084/jem.20151437
- Carlson T, Kroenke M, Rao P, Lane TE, Segal B. The Th17-ELR+ CXC chemokine pathway is essential for the development of central nervous system autoimmune disease. J Exp Med 2008;205(4):811–23. doi: https://doi.org/10.1084/jem.20072404
- Archambault AS, Sim J, McCandless EE, Klein RS, Russell JH. Region-specific regulation of inflammation and pathogenesis in experimental autoimmune encephalomyelitis. J Neuroimmunol 2006;181(1–2):122–32. doi: https://doi.org/10.1016/j.jneuroim.2006.08.012
- Blackmore S, Hernandez J, Juda M, Ryder E, Freund GG, Johnson RW, et al. Influenza infection triggers disease in a genetic model of experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A 2017;114(30):E6107–E6116. doi: https://doi.org/10.1073/pnas.1620415114
- Ochi H, Wu XM, Osoegawa M, Horiuchi I, Minohara M, Murai H, et al. Tc1/Tc2 and Th1/Th2 balance in Asian and Western types of multiple sclerosis, HTLV-I-associated myelopathy/tropical spastic paraparesis and hyperIgEaemic myelitis. J Neuroimmunol 2001;119(2):297–305. doi: https://doi.org/10.1016/S0165-5728(01)00393-9
- Lund BT, Ashikian N, Ta HQ, Chakryan Y, Manoukian K, Groshen S, et al. Increased CXCL8 (IL-8) expression in multiple sclerosis. J Neuroimmunol 2004;155(1–2):161–71. doi: https://doi.org/10.1016/j.jneuroim.2004.06.008
- Krakauer M, Sorensen P, Khademi M, Olsson T, Sellebjerg F. Increased IL-10 mRNA and IL-23 mRNA expression in multiple sclerosis: interferon-beta treatment increases IL-10 mRNA expression while reducing IL-23 mRNA expression. Multiple Scler J 2008;14(5):622–30. doi: https://doi.org/10.1177/1352458507087136
- Jablonska J, Wu CF, Andzinski L, Leschner S, Weiss S. CXCR2-mediated tumor-associated neutrophil recruitment is regulated by IFN-β. Int J Cancer 2014;134(6):1346–58. doi: https://doi.org/10.1002/ijc.28551
- Trenova AG, Slavov GS, Manova MG, Draganaova-Filipova MN, Mateva NG, Miteva LD, et al. Alterations in serum levels of IL-17 in contrast to TNF-alpha correspond to disease-modifying treatment in relapsing-remitting multiple sclerosis. Scand J Clin Lab Invest 2017;77(4):283–8. doi: https://doi.org/10.1080/00365513.2017.1303843
- Zindler E, Zipp F. Neuronal injury in chronic CNS inflammation. Best Pract Res Clin Anaesthesiol 2010;24(4):551–62. doi: https://doi.org/10.1016/j.bpa.2010.11.001
- Gajofatto A, Turatti M, Bianchi MR, Forlivesi S, Gobbin F, Azzarà A, et al. Benign multiple sclerosis: physical and cognitive impairment follow distinct evolutions. Acta Neurol Scand 2016;133(3):183–91. doi: https://doi.org/10.1111/ane.12442
- Correale J, Peirano I, and Romano L. Benign multiple sclerosis: a new definition of this entity is needed. Multiple Scler J 2012;18(2):210–8. doi: https://doi.org/10.1177/1352458511419702